Metformin is a widely used drug for the treatment of diabetes mellitus.

Metformin blocks important enzymes in cancer cells that are responsible for cancer growth and reproduction.

It also directly affects energy production within the cells. Responsible for energy production are the mitochondria. Metformin inhibits processes for electron transport within the mitochondria. As a result, the cancer cell can produce less energy and becomes weak.

Metformin indirectly leads to increased glucose uptake in the muscles. This reduces blood glucose and insulin levels. High levels of insulin are known to promote tumor growth and spread. A reduction in insulin by metformin can reduce the aggressiveness of cancer cells and prevent their further spread.

Metformin is also able to boost numerous chemotherapy regimens and thus improve the result of cancer therapy.

In addition to cancer therapy, metformin can also prevent cancer. Numerous studies confirm the preventive nature of metformin.

Studies have shown the effectiveness of metformin for the following types of cancer: Lung cancer, prostate cancer, colon cancer, breast cancer, and pancreatic cancer.

I recommend using metformin in cancer therapy. It is a well-known drug that is well tolerated and has many synergistic properties in cancer therapy.